Egalet earns FDA approval for abuse-deterrent opioid painkiller

The Food and Drug Administration on Monday approved Egalet Corp.’s long-acting opioid painkiller Arymo ER, reports Reuters.

Advertisement

Arymo ER is an extended-release form of morphine intended to prevent abuse by those seeking to dissolve and inject the drug. In August, an FDA advisory panel voted 18-1 in favor of the drug’s approval.

Egalet is a specialty pharmaceutical company located in Buffalo Grove, Ill. Its painkiller tablets are extremely hard, difficult to chew, resistant to particle size reduction and block attempts at chemical extraction of the active pharmaceutical ingredient, according to the company’s website.

More articles on supply chain:

Judge orders Sanofi, Regeneron’s cholesterol drug off the market following patent dispute
10 medical device trends for 2017
Director of supply chain named one of best jobs in America by CNNMoney

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.